Erin Cockrell
Pediatric Hematology-Oncology · Tampa, FLNPI 1255531455
Payments from drug & device makers
Across 483 payments — averaging $1937.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$319K
- Sanofi US Services Inc.$171K
- Sanofi$161K
- Bioverativ Therapeutics Inc.$72K
- Novo Nordisk AS$68K
- Genentech USA, Inc.$52K
- plus $92K from 27 others
Across 5 payments — averaging $320.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$2K
What the payments were for
- Consulting fees$142,24855%
- Speaking & faculty fees$89,26334%
- Travel & lodging$20,2968%
- Food & beverage$7,5603%
- Education$5030%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 91 | $319,245 |
| Sanofi US Services Inc. | 22 | $171,122 |
| Sanofi | 113 | $161,478 |
| Bioverativ Therapeutics Inc. | 20 | $72,481 |
| Novo Nordisk AS | 26 | $67,866 |
| Genentech USA, Inc. | 54 | $51,584 |
| Boehringer Ingelheim | 8 | $24,754 |
| Pfizer | 19 | $21,225 |
| Novo Nordisk | 12 | $19,008 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $8,495 |
| CSL Behring | 11 | $5,534 |
| Bayer | 7 | $3,545 |
| Global Blood Therapeutics, Inc. | 4 | $2,691 |
| HEMA Biologics, LLC | 6 | $2,515 |
| Boehringer Ingelheim RCV GmbH & Co KG | 30 | $1,583 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $1,126 |
| Jazz Pharmaceuticals Inc. | 6 | $357 |
| Novartis | 10 | $281 |
| Octapharma USA, Inc. | 3 | $211 |
| Astellas Pharma US Inc | 4 | $199 |
| Servier Pharmaceuticals LLC | 1 | $140 |
| Springworks Therapeutics, Inc. | 4 | $103 |
| Amgen | 2 | $98 |
| AstraZeneca(2 entities) | 5 | $96 |
| Boehringer Ingelheim B.v. | 8 | $65 |
| Genentech, Inc. | 2 | $54 |
| Agios Pharmaceuticals, Inc. | 2 | $42 |
| USWM, LLC | 2 | $39 |
| Y-mabs Therapeutics, Inc. | 1 | $25 |
| RARE Disease Therapeutics, Inc. | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Terumo BCT, Inc. | 1 | $17 |
| Emmaus Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$936,035 in reported general payments places this provider in the 95th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 13 | $384 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Tampa
- Juan RicoTampa$489K
- Don EslinTampa$459K
- Deepakbabu ChellapandianTampa$304K
- Dana ObzutTampa$127K
- Damon ReedTampa$28K
- Tung WynnGainesville$1M
- Guillermo DeanguloMiami$992K
- Ziad KhatibMiami$981K
- Shveta GuptaOrlando$822K
- Sridharan GururanganGainesville$801K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.